Table 1.
Association of ECT2 expression with clinicopathological characteristics of osteosarcoma patients.
| Variables | Cases (n=49) | ECT2 protein level | P value | ||
|---|---|---|---|---|---|
| Low (n=23) | High (n=26) | ||||
| Age (years) | ≤18 ys | 21 | 11 | 10 | 0.509 |
| >18 ys | 28 | 12 | 16 | ||
| Sex | Female | 18 | 8 | 10 | 0.790 |
| Male | 31 | 15 | 16 | ||
| Location | Tibia | 15 | 8 | 7 | 0.212 |
| Femur | 20 | 10 | 10 | ||
| Humeral | 10 | 2 | 8 | ||
| Others | 4 | 3 | 1 | ||
| Tumor grade | Low | 23 | 11 | 12 | 0.907 |
| High | 26 | 12 | 14 | ||
| Metastasis | Negative | 28 | 17 | 11 | 0.026* |
| Positive | 21 | 6 | 15 | ||
| Chemotherapy response | Good | 30 | 15 | 15 | 0.590 |
| Poor | 19 | 8 | 11 | ||
ECT2 – epithelial cell transforming sequence 2.